ProGenTech to Partner with China CDC to Develop Molecular Diagnostics | GenomeWeb
NEW YORK (GenomeWeb News) – Life sciences and molecular diagnostics company ProGenTech announced today that it has signed a collaborative agreement with the Chinese Center for Disease Control and Prevention to create a joint laboratory for developing next-generation molecular diagnostic systems and assays.
 
As part of its effort to develop integrated molecular diagnostics for pathogen detection and surveillance, the lab will employ ProGenTech’s Entura sample purification instrument platform and cassettes.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.